BlessUp Peptide Library · Immune & Recovery

The immune peptide class, decoded

Thymosin Alpha-1, Thymulin, Thymogen, Thymopentin. Four peptides from your thymus, and only one with real clinical evidence.

These modulate your immune system, they do not simply boost it. That distinction is the whole point.

4
thymic peptides in play, all studied for modulating immune function
35+
countries where Thymosin Alpha-1 is an approved medicine, for specific conditions
1
of the four carries genuine clinical evidence. The rest are far thinner

Thymosin Alpha-1 reduced mortality in severe COVID and in an earlier sepsis trial, though its largest, most rigorous sepsis trial (2025) was negative. Real evidence, honestly mixed. Full citations at the end.

You have seen them sold as immune boosters: Thymosin Alpha-1, Thymulin, Thymogen, Thymopentin, a family of peptides that come from or mimic hormones made by your thymus, the small gland behind your breastbone where your T-cells learn to fight.

Here is the honest version. The word "boost" is the wrong word. These are immune modulators: depending on the situation, they can help a worn-down or under-responsive immune system respond better, or help calm one that is over-firing. That is a genuinely different, and more interesting, idea than simply turning immunity up. And within the family, the evidence is wildly uneven. One member, Thymosin Alpha-1, is an approved medicine in dozens of countries with real clinical trials behind it. The other three are older, narrower, or rest mostly on Eastern-European studies. So the useful thing we can do is line each one up against what it actually does and the proof it actually has, honestly. We do honest, not hype.

Read this first

This is education, not medical advice, and it does not replace your own clinician. Of this class, only Thymosin Alpha-1 is a widely approved medicine (for specific conditions like hepatitis and as an immune adjunct); Thymulin, Thymogen, and Thymopentin are research peptides or approved only in certain regions. Because these change how your immune system behaves, they carry real cautions, especially in autoimmune disease and transplant. Any dose named here is an example for discussion, never a prescription.

90-second self-check

Are you cleared to explore this class, and which one fits?

This flags the immune hard stops, and if you are clear, points toward the compound that matches your goal. It is education, not a diagnosis or a recommendation to use anything.

Immune peptide readiness and fit

Answer honestly. Nothing is stored, and no one sees it but you.

First, the hard stops. Do any of these apply to you? (tap all that are true)

What are you actually weighing this class for?

Any of these in your picture? (tap all that apply)

Is the real immune foundation in place? (tap all that apply)

This reflection is education only, not a diagnosis or a recommendation to use any compound. Talk to a licensed provider about your own history and goals.

The basics

Four peptides from one gland

Your thymus is where T-cells, the coordinating cells of your immune system, are trained. It shrinks as you age, which is part of why immunity weakens over time. All four of these peptides are made by, or copied from, thymic hormones, and each nudges the immune system in a slightly different way:

  • Thymosin Alpha-1. A 28-amino-acid thymic peptide that helps T-cells mature and sharpens the response of dendritic cells (the immune system's scouts). The one with real clinical use.
  • Thymulin. A small thymic hormone that only works when bound to zinc, studied for restoring immune balance and calming inflammation.
  • Thymogen. A tiny two-amino-acid peptide, studied (largely in Eastern Europe) for mucosal and respiratory immune resistance, often given intranasally.
  • Thymopentin. A five-amino-acid fragment of another thymic hormone, studied for immune deficiency, with a very short life in the body.
CompoundThymic mechanismStudied forEvidence levelRoute
Thymosin Alpha-1T-cell maturation; dendritic / TLR signalingHepatitis, sepsis, cancer adjunct, vaccinesApproved in 35+ countries; real RCTsSubQ
ThymulinZinc-dependent thymic hormone; anti-inflammatoryImmune restoration, inflammation, painModest; needs zinc; thinner human dataSubQ
ThymogenDipeptide immunomodulator; mucosal immunityRespiratory infection resistanceMostly Eastern-European studiesIntranasal / IM
ThymopentinThymopoietin fragment; T-cell maturationImmune deficiency, some autoimmuneOlder, narrow-indication dataSubQ / IM

Two names to keep straight: this is Thymosin Alpha-1, not Thymosin Beta-4 (TB-500), which is a different, actin-based healing and repair peptide, not an immune modulator. And Thymalin is a thymus-extract complex (a mixture, not a single defined peptide), so it sits alongside this family rather than in it.

The honest half-truth you will hear

"They boost your immune system." Wrong verb. These modulate it, they help it respond appropriately, which in a healthy person is not obviously an improvement, and in someone with an over-active immune system could be the wrong direction entirely. And only Thymosin Alpha-1 has the clinical evidence to back specific medical uses. For the other three, the marketing is well ahead of the human data.

The part the marketing flattens

One of these is not like the others

They get sold on the same shelf as if the proof were equal. It is not, and the gap is dramatic. Here is an honest read of how much real human evidence sits behind each. Longer bars mean deeper, more rigorous human data, not "works better."

Depth of human evidence, by compound

Thymosin Alpha-1 is the clear outlier, an approved medicine with randomized trials. The rest thin out fast.

Thymosin Alpha-1
Approved, randomized trials
Thymopentin
Older, narrow-indication data
Thymulin
Modest; mostly mechanistic
Thymogen
Mostly Eastern-European studies

Thymosin Alpha-1: Liu 2020 (COVID) and Wu 2013 (an early sepsis RCT), with the honest counterweight that the larger 2025 sepsis trial (Wu, BMJ) was negative. The other three rest on older, regional, or mechanistic data. Full citations below.

Read the shape honestly. Thymosin Alpha-1 is a genuine, approved immune medicine with real randomized data. Thymopentin has older clinical use in a narrow indication. Thymulin and Thymogen are mostly mechanism and regional studies. If you are drawn to this class, the evidence points at one compound, not four.

Under the hood

How a thymic peptide tunes immunity

01

Train the T-cells

Thymic peptides help immature T-cells finish maturing into functional immune cells, the exact job the shrinking thymus does less of with age. More trained defenders, better coordinated.

02

Sharpen the scouts

Thymosin Alpha-1 in particular tunes dendritic cells and toll-like receptor signaling, the system that spots a threat and shifts the response toward the right kind of attack.

03

Modulate, not just amplify

The key word is modulate. In an under-responsive or exhausted immune system these can help it respond; the same signaling can also help rebalance an over-firing one. Context decides the direction, which is why autoimmunity is a caution.

That last point is the whole reason to be careful. A drug that helps your immune system respond more strongly is a good thing when you are fighting an infection and a potentially bad thing when your immune system is already attacking your own tissue. The mechanism cuts both ways.

The four, with honest pros and cons

Each one, against its evidence

Same thymic family, very different levels of proof. Tags show the standing: approved, modest, or thin.

Thymosin Alpha-1

Approved · the evidenced one

The 28-amino-acid thymic peptide that matures T-cells and sharpens the immune response. The one with real clinical trials and multi-country approval.

Pros
  • By far the deepest evidence of the class: approved in dozens of countries for specific conditions
  • A randomized trial reduced mortality in severe COVID by restoring exhausted T-cells, and an earlier sepsis trial suggested benefit
  • Used clinically for hepatitis B and C and as a vaccine and cancer-therapy adjunct, with a clean safety record over thousands of patients
Cons
  • Its largest, most rigorous sepsis trial (2025, over 1,000 patients) found no mortality benefit, so even its clinical picture is genuinely mixed
  • The strong data is in specific illnesses; general immune "optimization" in healthy people is extrapolated
  • Not FDA-approved in the United States (approved in many other countries)

Honest read: the sensible, best-proven choice if this class fits your situation, ideally with a provider. Given by subcutaneous injection.

Thymulin

Modest · zinc-dependent

A small thymic hormone that only works when bound to zinc, studied for restoring immune balance and calming inflammation.

Pros
  • An interesting anti-inflammatory and immune-balancing mechanism
  • Its zinc dependency ties it to a genuine, correctable nutrient (zinc status)
  • Studied for inflammation and pain models
Cons
  • Thinner human data than Thymosin Alpha-1; much is mechanistic or preclinical
  • Its activity depends on adequate zinc, an easy thing to overlook
  • A research peptide, not an established therapy for general use

Honest read: mechanistically interesting, clinically under-proven. Zinc status matters. Given by subcutaneous injection.

Thymogen

Thin · mucosal

A tiny two-amino-acid peptide, studied largely in Eastern Europe for respiratory and mucosal immune resistance, often given intranasally.

Pros
  • Simple, well-tolerated, and convenient by the intranasal route
  • A real history of use for respiratory-infection resistance in its region
  • Low-drama profile in the available data
Cons
  • The human evidence is mostly Eastern-European and does not meet Western trial standards
  • General immune benefit is extrapolated, not demonstrated in rigorous trials
  • A research peptide outside its approval regions

Honest read: the lightest and least-proven of the group. Real regional use, thin rigorous data. Often intranasal.

Thymopentin

Modest · older data

A five-amino-acid fragment of the thymic hormone thymopoietin, studied for immune deficiency, with a very short life in the body.

Pros
  • Genuine older clinical use in immune deficiency and some autoimmune contexts
  • A well-defined active fragment with a clear mechanism
  • Decades of accumulated experience in its indications
Cons
  • Its data is older and narrow, not a broad modern evidence base
  • A very short half-life in the body means frequent dosing
  • Largely superseded by Thymosin Alpha-1 in modern practice

Honest read: a real but dated immune-deficiency tool, outpaced by Thymosin Alpha-1. Given by injection, dosed frequently.

The line that matters most

Modulation is not the same as more

The single most important idea in this class is the difference between boosting and modulating. Marketing sells the fantasy of turning your immune system up like a dial. What thymic peptides actually do is help the immune system respond more appropriately, which is genuinely useful when it is worn down, exhausted, or under-responding, and genuinely risky when it is already over-firing. A healthy, well-functioning immune system is not obviously improved by pushing on it.

Two things to hold onto

First, the evidence points at one compound: Thymosin Alpha-1 is the member with real clinical trials, and even its strong data is in specific illnesses, not general wellness. Second, because these change immune behavior, autoimmune disease and transplant are not "go slower" situations, they are stop-and-ask-a-specialist ones. The mechanism is the caution.

The most important section here

The immune hard stops and cautions

Because these change how your immune system behaves, a few situations are genuinely off-limits without a specialist, and the reasons are the mechanism itself.

1

Autoimmune disease

In an autoimmune condition, your immune system is already attacking your own tissue. A compound that helps the immune system respond more strongly can push in exactly the wrong direction. Lupus, rheumatoid arthritis, MS, autoimmune thyroid, inflammatory bowel disease, and others are firm reasons to stop and involve a specialist, not to self-experiment.

2

Organ transplant or immunosuppressant medication

After a transplant, the entire goal of your medication is to hold your immune system down so it does not reject the organ. An immune-stimulating peptide works directly against that. This is a hard stop.

3

Pregnancy and breastfeeding

These are not established as safe in pregnancy or breastfeeding. Clear that first.

4

Cancer: nuanced, and a provider decision

This one is genuinely context-dependent. Thymosin Alpha-1 is actually studied as an add-on to cancer immunotherapy, so immune support can be part of a plan, but only one directed by an oncologist. Do not improvise it around active cancer or treatment.

5

Research-compound status of the other three

Thymulin, Thymogen, and Thymopentin are research peptides or approved only in certain regions, with thinner safety data and uncertain sourcing. Treat them as experimental, and favor the evidenced option if you proceed at all.

The one rule under all of it

If you have any autoimmune condition or a transplant, this class is not a self-directed project, full stop. Otherwise, favor the one with real evidence (Thymosin Alpha-1), involve a provider, and build the immune foundation below first, because it does more than any of these for a healthy person.

Put it together

How to think about choosing, honestly

First question

Are you cleared at all?

  • No autoimmune disease
  • No transplant and not on immunosuppressants
  • Not pregnant or breastfeeding; cancer handled with an oncologist
  • If an immune hard stop is present, this class is not the tool, full stop

Second question

Which one, and is it worth it?

  • If anything, the evidenced choice is Thymosin Alpha-1
  • The other three are thinner, older, or regional, treat as experimental
  • For a healthy person, the foundation below outperforms all of them
  • Anything here belongs in a provider conversation, not a solo protocol

The move most people skip

Ask whether your immune system actually needs modulating. For a healthy person, sleep, nutrition, and stress do far more than any of these. Match the tool to a real need, favor the evidenced option, and keep a provider in the loop. Matching beats maxing.

The foundation under everything

What actually builds immunity

For a healthy person, the immune interventions with the strongest evidence are not peptides, they are habits. These do more than anything on the shelf, and the peptides only nudge on top.

Sleep

Sleep is where the immune system consolidates and repairs. Short or broken sleep measurably weakens your response to infection and vaccines. No peptide compensates for it. Fix this first.

Nutrition: protein, zinc, vitamin D

Your immune system is built from protein, and it depends on specific nutrients, zinc (which Thymulin literally requires to work) and vitamin D chief among them. Correcting a real deficiency does more than any peptide.

Exercise and a healthy weight

Regular moderate exercise and good metabolic health keep the immune system responsive; chronic inactivity and excess weight blunt it. Free, and evidence-backed.

Stress, and not smoking

Chronic stress and smoking both suppress immune function directly. Managing stress and not smoking are among the highest-leverage immune moves there are, and they cost nothing.

Cutting through the noise

Support, graded honestly

Solid

Sleep, adequate protein, and correcting real zinc or vitamin D deficiency

The genuinely evidence-backed base of immune health. This does more than any peptide for a healthy person. Boring, and it works.

Reasonable

Zinc (especially if low), vitamin D to a normal level, and exercise

Sensible, well-supported support, especially zinc given its direct role in thymic-hormone activity. Follow the labs, not the hype.

Unproven

Thymulin, Thymogen, or Thymopentin for general "immune boosting"

Thin, older, or regional evidence, and "boosting" a healthy immune system is not a clear benefit. Curiosity, not confidence.

Skip

Any immune peptide while you have an autoimmune condition or a transplant, without a specialist

The exact situation where an immune modulator can push in the wrong direction. This is a specialist decision, never a self-directed one.

Turn this into action

Questions to ask yourself

Have I honestly ruled out the hard stops: any autoimmune disease, a transplant or immunosuppressants, and pregnancy?

Does my immune system actually need modulating, or is a healthy one being pushed for no reason?

Is my sleep, nutrition (including zinc and vitamin D), and stress actually handled first?

If I proceed, am I choosing the one with real evidence (Thymosin Alpha-1), not the thinnest option?

Is a knowledgeable provider genuinely involved?

Bring these to your visit

Questions to ask your provider

Given my history, is any immune-modulating peptide safe for me, especially with my autoimmune or medication picture?

Is there an actual reason to modulate my immune system, or is the foundation the better lever?

Should we check zinc, vitamin D, and other immune-relevant labs first?

What symptoms (a flare, an infection) should make me stop and call you?

Stop and get medical help

A few situations are not "go slower," they are "stop and be seen."

  • A flare of an autoimmune condition (new or worsening joint, skin, gut, or nerve symptoms)
  • Signs of transplant rejection if you have a transplant
  • A severe allergic reaction: swelling of the face or throat, trouble breathing
  • A new fever, spreading redness, or feeling very unwell
  • Any new or unusual lump or symptom you are worried about

A mild injection-site reaction settles. An autoimmune flare or signs of rejection do not wait, they are specialist emergencies. When in doubt, be seen.

The BlessUp take

Modulate with respect, and stand on the evidence

The idea here is real and elegant: your thymus trains your immune defenders, it fades with age, and these peptides are studied for helping that system respond better. But two honest truths run underneath all the marketing. First, this is modulation, not a boost, which means it is genuinely useful when the immune system is worn down and genuinely risky when it is over-firing, so autoimmune disease and transplant are hard lines, not cautions. Second, the evidence is not spread evenly across the four. Thymosin Alpha-1 is a real, approved medicine with randomized trials behind it, with a genuine mortality benefit in severe COVID and an early sepsis trial, even if its largest recent sepsis trial came back negative. The other three are older, narrower, or regional. So do not confuse the family for the evidence. For a healthy person, sleep, nutrition, zinc, and stress do more than any of these. And if you do have a real reason to modulate immunity, favor the one with the proof, and do it with a provider. That is not the cautious move. It is the one that respects how immunity actually works.

The evidence

Sources

Retrieved from PubMed. Thymosin Alpha-1 carries the class's real randomized-trial evidence (shown here in sepsis and severe COVID); the other three rest on older, regional, or mechanistic data without comparable rigorous trials.

  1. Wu J, Zhou L, Liu J, et al. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit Care. 2013;17(1):R8. doi:10.1186/cc11932 (361-patient RCT; 28-day mortality 26% vs 35%)
  2. Liu Y, Pan Y, Hu Z, et al. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells. Clin Infect Dis. 2020;71(16):2150-2157. doi:10.1093/cid/ciaa630 (severe COVID mortality 11% vs 30%)
  3. Wu J, Pei F, Zhou L, et al. The efficacy and safety of thymosin alpha 1 for sepsis (TESTS): multicentre, double-blinded, randomised, placebo-controlled, phase 3 trial. BMJ. 2025;388:e082583. doi:10.1136/bmj-2024-082583 (the honest counterweight: no mortality benefit in 1,106 patients, HR 0.99)

Citations retrieved from PubMed. Thymosin Alpha-1's strong evidence is in specific illnesses, not general wellness in healthy people. Thymulin, Thymogen, and Thymopentin have thinner (modest, older, or Eastern-European) evidence and are research or regionally-approved compounds. This report is an honest educational map of the class, not a dosing sheet or a recommendation to use any compound.